Skip to main content
. 2016 Oct 1;55(19):2749–2758. doi: 10.2169/internalmedicine.55.6730

Figure 1.

Figure 1.

Patients who did not receive the recommended management strategy. One hundred and seven (32.1%) of 333 patients diagnosed with hepatocellular carcinoma (HCC) deviated from the management strategy as follows: 40/107 patients did not undergo screening, 23/107 patients did not undergo examinations, and 44/107 patients did not undergo treatment. An optimal follow-up was thus achieved in 226 (67.9%) patients.